Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02422589 |
Title | A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors |
Recruitment | Completed |
Gender | |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ITA | ESP | DNK |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Karmanos Cancer Institute Oncology Department | Detroit | Michigan | 48201 | United States | Details | |
Henry Ford Hospital SC | Detroit | Michigan | 48202-2689 | United States | Details | |
Cancer Therapy & Research Center UT Health Science Center SC-4 | San Antonio | Texas | 78229 | United States | Details | |
Novartis Investigative Site | Copenhagen | DK-2100 | Denmark | Details | ||
Novartis Investigative Site | Milano | MI | 20133 | Italy | Details | |
Novartis Investigative Site | Rozzano | MI | 20089 | Italy | Details | |
Novartis Investigative Site | Modena | MO | 41124 | Italy | Details | |
Novartis Investigative Site | Padova | PD | 35100 | Italy | Details | |
Novartis Investigative Site | La Coruna | Galicia | 15006 | Spain | Details | |
Novartis Investigative Site | Madrid | 28046 | Spain | Details | ||
Novartis Investigative Site | Madrid | 28050 | Spain | Details |